Abbvie’s another attempt to get health insurance benefit for ‘Duodopa’

A Parkinson’s disease treatment, ‘Duodopa Intestinal Gel,’ made the second challenge for the health insurance registration.

According to the industry concerned on the 9^th, Abbvie’s Duodopa(carbidopa, levodopa) which received judgement of uninsured benefit will be re-introduced at the Health Insurance Review & Assessment Service’s Insurance Benefit Deliberation Committee soon.

Despite all th...